Literature DB >> 11574594

Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.

K Lee1, J K Lim, D Yong, J Yum, Y Chong, R Okamoto, M Inoue.   

Abstract

The disk screening methods for extended-spectrum beta-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to < or =20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime- and ceftazidime-clavulanic acid disks are stable at -20 degrees C for 12 weeks.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11574594      PMCID： PMC88410          DOI： 10.1128/JCM.39.10.3696-3699.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

Review 1.  Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?

Authors:  A Bauernfeind; Y Chong; K Lee
Journal:  Yonsei Med J       Date:  1998-12       Impact factor: 2.759

2.  Evaluation of stability of cefotaxime (30-microg) and ceftazidime (30-microg) disks impregnated with clavulanic acid (10 microg) for detection of extended-spectrum beta-lactamases.

Authors:  C Watt; M Louie; A E Simor
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  Korean Nationwide Surveillance of Antimicrobial Resistance of Bacteria in 1998.

Authors:  K Lee; C L Chang; N Y Lee; H S Kim; K S Hong; H C Cho
Journal:  Yonsei Med J       Date:  2000-08       Impact factor: 2.759

4.  Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea.

Authors:  J Kim; Y Kwon; H Pai; J W Kim; D T Cho
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  The use of analytical isoelectric focusing for detection and identification of beta-lactamases.

Authors:  A Mathew; A M Harris; M J Marshall; G W Ross
Journal:  J Gen Microbiol       Date:  1975-05

7.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

Authors:  P A Bradford; C Urban; N Mariano; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

8.  Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

Authors:  K S Thomson; C C Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

9.  Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.

Authors:  H Pai; S Lyu; J H Lee; J Kim; Y Kwon; J W Kim; K W Choe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 10.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.